Ultrasensitive colorimetric detection of creatinine via its dual binding affinity for silver nanoparticles and silver ions

Jingle Huang,Maria Sokolikova,Antonio Ruiz-Gonzalez,Yingqi Kong,Yuxuan Wang,Yingjia Liu,Lizhou Xu,Mingqing Wang,Cecilia Mattevi,Andrew Davenport,Tung-Chun Lee,Bing Li
DOI: https://doi.org/10.1039/d3ra08736k
IF: 4.036
2024-03-19
RSC Advances
Abstract:Creatinine is an important biomarker for the diagnosis of chronic kidney disease (CKD). Recently, it has been reported that the concentration of salivary creatinine correlates well with the concentration of serum creatinine, which makes the former useful for the development of non-invasive and point-of-care (POC) detection for CKD diagnosis. However, there exists a technical challenge in the rapid detection of salivary creatinine at low concentrations of 3–18 μM when using the current kidney function test strips as well as the traditional methods employed in hospitals. Herein, we demonstrate a simple, sensitive colorimetric assay for the detection of creatinine with a limit-of-detection (LOD) down to the nanomolar level. Our approach utilises the dual binding affinity of creatinine for citrate-capped silver nanoparticles (Ag NPs) and Ag( I ) ions, which can trigger the aggregation of Ag NPs and thus lead to the colour change of a sample. The quantitative detection of creatinine was achieved using UV-Vis spectroscopy with a LOD of 6.9 nM in artificial saliva and a linear dynamic range of 0.01–0.06 μM. This method holds promise to be further developed into a POC platform for the CKD diagnosis.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a simple, rapid and sensitive colorimetric method for detecting creatinine in saliva, in order to achieve the early diagnosis of chronic kidney disease (CKD). Currently, the rapid detection of low - concentration creatinine (3 - 18 μM) in saliva faces technical challenges, especially when using existing kidney function test strips and traditional hospital methods. This paper proposes a colorimetric method based on the dual - binding affinity of silver nanoparticles (Ag NPs) and silver ions (Ag(I)), which can detect creatinine concentrations at the nanomolar level and has high sensitivity and specificity. ### Main research contents 1. **Research background**: - Creatinine is an important biomarker for diagnosing chronic kidney disease (CKD). - The creatinine concentration in saliva is related to that in serum, making it a useful tool for non - invasive and point - of - care (POC) testing. - Existing kidney function test strips and traditional methods have technical challenges in detecting low - concentration saliva creatinine. 2. **Research methods**: - Use citrate - capped silver nanoparticles (citrate - capped Ag NPs) as the main sensing probe, with an initial color of light yellow. - The addition of creatinine triggers ligand exchange between creatinine and citrate ions, forming creatinine - capped silver nanoparticles. - Subsequently, silver ions (Ag(I)) are added, causing the aggregation of silver nanoparticles and the color changing to blue - gray. - Quantitatively detect the creatinine concentration by ultraviolet - visible spectroscopy (UV - Vis spectroscopy), or qualitatively detect it by visual observation. 3. **Experimental results**: - The limit of detection (LOD) of this method for creatinine in artificial saliva is 6.9 nM, and the linear dynamic range is 0.01 - 0.06 mM. - This method has good selectivity for different interfering substances (such as metal ions, non - metal ions, trace biomolecules, etc.). - The applicability of this method in actual saliva samples was verified by diluting artificial saliva samples. ### Conclusion This study successfully developed a sensitive colorimetric method that can detect creatinine in saliva at the nanomolar level, with a low limit of detection and good selectivity. This method is expected to be further developed into a point - of - care testing platform for the early diagnosis of chronic kidney disease, especially suitable for clinical environments with limited resources.